Peer-influenced content. Sources you trust. No registration required. This is HCN.
Dana-Farber Cancer Institute
A recent study on glioma brain tumors reveals the significant role of epigenetic changes in tumor formation. This discovery offers promising avenues for targeted therapies, potentially transforming the approach to treating this devastating disease.
Oncology, Medical August 14th 2023
Oncology News Central (ONC)
Learn about a ground-breaking strategy for treating uncommon brain tumors like papillary craniopharyngiomas (PCPs), where precision medicine and BRAF/MEK inhibitors marked a major improvement in brain cancer treatment by drastically reducing tumor size.
Neurology July 18th 2023
Cancer Therapy Advisor
Amar Gajjar, MD, who serves as the co-chair of the oncology department and chair of the pediatric medicine department at St. Jude Children’s Research Hospital in Memphis, Tennessee, answers questions from our friends at Cancer Therapy Advisor. Proton therapy, conventional chemotherapy, targeted therapies, and observed glioma progression are all topics covered by Dr. Gajjar when talking about treatment options for pediatric low-grade gliomas (pLGG) that have relapsed or progressed.
Neurology November 14th 2022